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Catch-up growth in juvenile rats, fat expansion, and
dysregulation of visceral adipose tissue
Esther Lizarraga-Mollinedo1, Gemma Carreras-Badosa1, Silvia Xargay-Torrent1, Xavier Remesar2,3, Berta Mas-Pares4, Anna Prats-Puig5,
Francis de Zegher6, Lourdes Ibáñez7,8, Abel López-Bermejo1,9,10 and Judit Bassols4
BACKGROUND: Accelerated catch-up growth following intrauterine restriction increases the risk of developing visceral adiposity
and metabolic abnormalities. However, the underlying molecular mechanisms of such metabolic programming are still poorly
understood.
METHODS: A Wistar rat model of catch-up growth following intrauterine restriction was used. A gene expression array was
performed in the retroperitoneal adipose tissue sampled at postnatal day (PD) 42.
RESULTS: Five hundred and forty-six differentially expressed genes (DEGs) were identified (adjusted p value < 0.05). Gene ontology
enrichment analysis identified pathways related to immune and lipid metabolic processes, brown fat cell differentiation,
and regulation of PI3K. Ccl21, Npr3, Serpina3n, Pnpla3, Slc2a4, and Serpina12 were validated to be upregulated in catch-up pups (all
p < 0.01) and related to several fat expansion and metabolic parameters, including body weight at PD42, postnatal body weight
gain, white and brown adipose tissue mass, plasma triglycerides, and insulin resistance index (all p < 0.05).
CONCLUSIONS: Genes related to immune and metabolic processes were upregulated in retroperitoneal adipose tissue following
catch-up growth in juvenile rats and were found to be associated with fat expansion and metabolic parameters. Our results provide
evidence for several dysregulated genes in white adipose tissue that could help develop novel strategies to prevent the metabolic
abnormalities associated with catch-up growth.
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IMPACT:
● Catch-up growth presents several dysregulated genes in white adipose tissue related to metabolic abnormalities.
● Ccl21, Npr3, Serpina3n, Pnpla3, Slc2a4, and Serpina12 were validated to be upregulated in catch-up pups and related to visceral
fat expansion and metabolic parameters.
● Profiling and validation of these dysregulated genes in visceral adipose tissue could help develop novel strategies to prevent
the metabolic abnormalities associated with catch-up growth.
INTRODUCTION
Obesity is a relevant medical condition that has the dimension of a
global epidemic and carries the risk of developing other
noncommunicable diseases, such as type 2 diabetes (T2D) and
coronary artery disease.1 Accumulating evidence reveals that
nutrition has a critical role during crucial periods of development,
including the intrauterine life.2,3 The concept of the “thrifty
phenotype hypothesis” states that nutritional insults affecting
intrauterine growth make the fetus adopt survival strategies,
through metabolic adaptations, to optimize the use of nutrients
and prioritize the growth of certain organs, such as the brain, at
the expense of others, mostly peripheral organs.4 Although these
adjustments can benefit the individual in the short term, they will
be potentially detrimental under subsequent conditions of
abundant nutrient supply since the organism remains pro-
grammed to scarcity conditions.5–9 Negative consequences of
such metabolic programming include the development of obesity
and the associated metabolic diseases later in life.5,8
Studies in low birth weight children have pointed out that early
postnatal catch-up growth, rather than having reduced prenatal
growth, increases the risk of developing cardiometabolic diseases
later in life.10,11 Animal models showed that even before any
catch-up growth is evident, prenatally restricted rats exhibit
physiologic, morphologic, and transcriptomic defects that can be
considered as the initial signs of metabolic programming, which
can be worsened or readapted with catch-up growth.12 Several
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studies have reported that low birth weight children with catch-up
growth manifest abnormalities already at school age, such as
precocious puberty, overweight, augmented adiposity, insulin
resistance, and low-grade inflammation.13–17 Despite the robust
associations of these studies, the molecular mechanisms mediat-
ing the interaction between catch-up growth and metabolic-
related conditions are still largely unknown.
Adipose tissue has been identified as one of the principal
targets of such metabolic programming, as emerging evidence
has linked catch-up growth to the excess of adipose tissue and
impaired metabolism in animal models. Pigs that experienced
early catch-up growth developed a remarkable increase in
adiposity and an abnormal lipid profile after both chow diet
feeding18 and high fat diet feeding.19 Studies in rats have come to
similar results: restricted rats following high caloric or chow diets
increased their fat storage and showed a deleterious metabolic
phenotype.20
Previous results in our laboratory showed that catch-up growth
following intrauterine restriction in rats increased the adipocyte
size in the retroperitoneal fat pad, and presented a higher amount
of circulating triglycerides and higher homeostatic model assess-
ment of insulin resistance (HOMA-IR), indicating the role of catch-
up in fat accumulation and metabolism alterations.21 Several
studies of adult animals with intrauterine restriction and
subsequent catch-up have been developed to describe the genes
in the adipose tissue playing important roles in the development
of catch-up-associated metabolic disorders and their comorbid-
ities.22,23 However, little is known about the gene profiling at
earlier stages, such as at school age. We hypothesize that the gene
profile of retroperitoneal adipose tissue already at a juvenile time-
point will be dysregulated in catch-up rats.
Herein, we aimed to study the gene expression profile in the
retroperitoneal adipose tissue of juvenile rats with intrauterine
restriction and postnatal catch-up growth compared to
those without catch-up growth in order to better understand
the molecular mechanisms involved in catch-up growth.
MATERIALS AND METHODS
Animal model
All studies were approved by the Animal Research Ethics
Committee (C.E.E.A., #DAAM 6911) of the University of Barcelona
according to the principles and procedures outlined in the Catalan
Government guideline 214/97. Wistar rats (Janvier, Le Genest Saint
Isle, France) were bred and maintained under control conditions
(22 °C, 12:12 light–dark cycle, humidity 50%, free access to water)
and fed a standard laboratory chow (Teklad Global Rodent
Maintenance Diet, Harlan Laboratories Inc.; 14% protein, 4% fat,
2900 kcal/kg). A model of intrauterine restriction induced by
caloric restriction throughout gestation was developed as
described previously21 (Supplementary Fig. S1). Briefly, virgin
females were housed with males overnight and mating was
confirmed by observation of spermatozoa in vaginal smears. From
day 1 of gestation, the dams were then housed individually. Dams
were fed on a 50% calorie-restricted diet during gestation to
obtain pups with low birth weight (R). During suckling, dams were
fed with standard rat chow to obtain catch-up growth pups (R/C)
or were kept on a calorie-restricted diet to obtain restricted pups
(R/R). An additional control group (C/C) was also present to
confirm both catch-up growth and restriction events.21 At
postnatal day 22 (PD22), weaning pups were weighed, separated
from their mothers, and provided with a chow diet ad libitum till
PD42. Body weights from PD1 until PD42 were recorded. At the
end of the experiment, pups that were fasted overnight were
anesthetized with 3% isoflurane and euthanized by cardiac
exsanguination. After dissection, tissues (retroperitoneal and
interscapular brown adipose tissues) were weighed for assessment
of body composition and stored at −80 °C until analysis.21 Plasma
samples were obtained from blood extracted during the cardiac
exsanguination, collected in heparinized syringes, and centrifuged
at 3500 r.p.m. for 15 min at 4 °C. Glucose and triglycerides were
determined by dry chemistry technique (Spotchem II, Spotchem
EZ SP-4410, Menarini Diagnostics-Akray, Japan) and insulin and
total adiponectin levels were measured by enzyme-linked
immunosorbent assay (ELISA) using a commercial kit (Ultrasensi-
tive Rat Insulin ELISA kit and Rat Adiponectin ELISA kit, Crystal
Chem Inc.) as previously described.21 HOMA-IR was also calculated
as published before.24 As sex differences in anthropometric or
biochemical parameters were not found, both females and males
were used in the study.
Gene expression array
Gene expression profiling was performed using retroperitoneal
adipose tissue of eight R/C samples and eight R/R samples (four
females and four males, randomly selected from different litters
per each group) using Affymetrix Rat Expression Array (Clariom S
Array, Affymetrix, California). Total RNA was extracted from
homogenized retroperitoneal adipose tissue with Qiazol lysis
reagent (Qiagen, Venlo, The Netherlands), subsequently purified
by RNAeasy mini kit (Qiagen) and coupled with on-column DNase
digestion by RNase-free DNase Set (Qiagen) according to the
manufacturer’s instructions. RNA integrity was tested with the
Agilent 2100 Bionanalyzer (Agilent Technologies, California).
Arrays were performed at the High Technology Unit in Vall
d’Hebron Research Center (Barcelona, Spain) following the
Affymetrix standard protocols. Raw data were extracted and
analyzed using Affymetrix Transcriptome Analysis Console 4.0 soft-
ware (TAC, Affymetrix, California). Briefly, the probe signal values
were log transformed, background corrected, and quantile
normalized. Comparison between catch-up and non-catch-up
groups was set and differentially expressed genes (DEGs) were
identified using the following criteria log2 fold change (FC) >3 and
<−3, and false discovery rate (FDR)-adjusted p value < 0.05 to
avoid false-positive issues. Gene Ontology (GO) enrichment
analysis of DEGs was performed with Gene Ontology enRIchment
anaLysis and visuaLizAtion tool (GOrilla, Multi Knowledge Project)25
considering an FDR-adjusted p value < 0.05. Afterwards, Reduce
and Visualize Gene Ontology (REViGO) software26 was used to
remove redundancy and cut down the number of significant
pathways. Afterwards, the pathways containing any of the 20 top-
ranked upregulated or downregulated DEGs were selected. Finally,
all DEGs present in the selected pathways were chosen to be
validated.
Real-time quantitative PCR (RT-qPCR) analysis
Genes selected for validation were analyzed in 16 rat samples per
group (R/C, R/R, and C/C samples; 1/2 females and 1/2 males). Total
RNA was isolated from adipose tissue as described above and was
retro-transcribed to complementary DNA (cDNA) by High-capacity
cDNA Reverse Transcription kit (Applied Biosystems, Thermo Fisher
Scientific). Gene expression was assessed by RT-qPCR using the
LightCycler 480 Real-Time PCR System (Roche Diagnostics, India-
napolis), according to the manufacturer’s protocol. Taqman Gene
Expression Assays were purchased from Applied Biosystems for
Adrb3 (Rn00565393_m1), Agt (Rn00593114_m1), Apod (Rn00562832
_m1), Ccl19 (Rn01439563_m1), Ccl21 (Rn01764651_g1), Cd28
(Rn00565469_m1), Cd79b (Rn00591795_m1), Cr2 (Rn04244351
_m1), Igf1 (Rn00710306_m1), Itk (Rn01496863_m1), Npr3
(Rn00563495_m1), Pck1 (Rn01529014_m1), Plac8 (Rn01450126
_m1), Pnpla3 (Rn01502361_m1), Pparg (Rn00440945_m1), Slc2a4
(Rn00562597_m1), Sema4d (Rn01435039_m1), Serpina3n
(Rn00755832_mH), Serpina12 (Rn01518409_m1), and Ucp1
(Rn00562126_m1) genes. Data obtained were normalized to the
expression of housekeeping gene Gapdh (Rn01775763_g1). Relative
gene expression was retrieved using the comparative threshold (Ct)
method and is presented as relative expression (2−ΔCt).
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SPSS 22.0 (SPSS software, IBM) was used for statistical analyses. For
array analysis, p values were calculated by analysis of variance
(ANOVA) using the TAC 4.0 software. For validation analysis,
unpaired t test was used to establish significant differences
between R/C and R/R groups. Differences with p value < 0.05 were
considered significant. Spearman’s correlation was performed to
analyze associations between gene expression and body composi-
tion and metabolic parameters. Bonferroni correction for multiple
comparisons was made by applying a p value ≤ 0.01 (0.05 divided
by 5 validated genes). Multiple linear regression analyses adjusting
by sex were done to confirm significant correlations seen between
gene expression and body composition or metabolic parameters.
When necessary, logarithmic transformation was used to achieve
the normal distribution of continuous variables.
RESULTS
Animal model
In this catch-up animal model, previously used and characterized
by our laboratory,21 R/C and R/R had similar birth weight at PD1 but
body weight at PD22 and PD24, as well as body weight gain was
higher in R/C compared to R/R (Supplementary Fig. S1), indicating
that R/C was caught up in weight. Moreover, in a previous
publication, we also showed that R/C pups presented accelerated
catch-up growth in comparison to C/C control group, and R/R pups
presented restriction in comparison to C/C control group.21 R/C
pups also showed higher accumulation of retroperitoneal adipose
tissue, were more insulin resistant (higher glucose, insulin, and
HOMA-IR index), and had higher levels of plasma triglycerides and
lower total adiponectin compared to R/R (Table 1).
Gene expression profile of retroperitoneal adipose tissue: array
analysis
The Rat Clariom S Array (Affymetrix) performed in retroperitoneal
adipose tissue analyzed 21,848 coding gene transcripts. From all
of them, 546 (2.5%) were found to be DEGs between the R/C and
R/R groups (│log2FC│ > 3 and FDR-adjusted p value < 0.05)
(Fig. 1a). Of the 546 DEGs, 327 were upregulated and 219 were
downregulated (Fig. 1b and Supplementary Table S1).
GO analysis retrieved enrichment in 172 different biological
pathways (Supplementary Table S2). After summarizing and
removing the redundant GO terms with REViGO, 56 pathways
were grouped according to semantic similarity (Fig. 1c and
Supplementary Table S2). In order to validate genes with
functional relevance, we identified the pathways that contained
genes from the 20 top-ranked upregulated or downregulated
DEGs. Using this combined approach, six pathways were
selected: immune system process, together with regulation of
leukocyte proliferation and response to cytokines, lipid metabolic
process, brown fat cell differentiation, and regulation of PI3K
(Fig. 1d).
Then, all genes from our DEGs from these six selected pathways
were chosen to be validated in all study samples: Cd79b, Itk, Cr2,
Npr3, Ccl19, Ccl21, and Serpina3n related to the immune system;
Apod, Pck1, and Pnpla3 related to lipid metabolism; Adrb3, Plac8,
Pparg, Slc2a4, and Ucp1 for brown fat-related pathways; and Agt,
Cd28, Igf1, Sema4d, and Serpina12 for positive regulation of PI3K
(Fig. 1e, f).
DEGs between R/C and R/R: validation analysis
The validation by RT-qPCR demonstrated that Ccl21 (response to
cytokines) was significantly downregulated and Npr3 (regulation
of leukocyte proliferation); Serpina3n (response to cytokines)
Pnpla3 (lipid metabolic process), Slc2a4 (related to brown fat cell
differentiation), and Serpina12 (positive regulation of PI3K) were
significantly upregulated in R/C vs R/R group (Fig. 2). Differential
gene expression was not confirmed for the remaining selected
genes. Available C/C control group from the experimental setting
was also assessed for confirmation. In all cases, the C/C control
group gene expression was in between gene expression of R/R
and R/C groups (Fig. 2).
Table 1. Body composition and metabolic parameters of the studied groups.
R/C R/R C/C P value
n= 16 n= 16 n= 16
Body composition
Body weight PD1 (g) 5.17 ± 0.29 5.11 ± 0.25 6.51 ± 0.27 NS
Body weight PD22 (g) 51.64 ± 4.78 18.28 ± 1.16 41.81 ± 3.91 <0.001
Body weight PD42 (g) 178.90 ± 21.58 86.33 ± 11.50 165.56 ± 20.78 <0.001
Postnatal body weight gain (g) 173.72 ± 21.56 81.22 ± 11,58 159.05 ± 20.62 <0.001
Postnatal body weight gain (%) 33.67 ± 4.40 15.97 ± 2.67 24.39 ± 2.72 <0.001
Retroperitoneal AT (g) 1.02 ± 0.33 0.26 ± 0.08 0.74 ± 0.24 <0.001
Retroperitoneal AT/BW PD42 (%) 0.57 ± 0.14 0.31 ± 0.09 0.44 ± 0.10 <0.001
Brown AT (g) 0.36 ± 0.06 0.17 ± 0.03 0.30 ± 0.09 <0.001
Brown AT/BW PD42 (%) 0.21 ± 0.03 0.19 ± 0.04 0.18 ± 0.05 NS
Serum parameters
Glucose (mmol/L) 9.73 ± 0.49 8.91 ± 0.89 9.98 ± 0.74 0.016
Insulin (pmol/L) 329.1 ± 21.1 195.1 ± 53.5 247.1 ± 23.1 0.010
HOMA-IR index 3.55 ± 1.12 1.25 ± 0.37 3.05 ± 0.87 <0.001
Triglycerides (mmol/L) 1.41 ± 0.49 0.75 ± 0.27 1.25 ± 0.40 0.001
Total adiponectin (mg/g) 10.5 ± 5.9 21.4 ± 12.6 25.7 ± 12.6 0.015
Values are expressed as mean ± standard deviation.
Significant p value < 0.05 comparing R/C vs R/R groups are shown in bold.
R/R non-catch-up group, R/C catch-up group, PD postnatal day, AT adipose tissue, BW body weight, HOMA-IR index homeostatic model assessment of insulin
resistance, NS nonsignificant.
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Fig. 1 Functional enrichment analysis of differentially expressed genes (DEGs) using Gene Ontology (GO) analysis. a Heatmap of the 546
DEGs detected by the gene expression profile of retroperitoneal adipose tissue. b Summary of upregulated and downregulated DEGs in R/C as
compared to R/R. c Semantic similarity-based scatterplot of the relevant pathways using all DEGs performed with REViGO. Bubble color
indicates the user-provided p value, and size indicates the frequency of the GO term in the underlying GO analysis database. d Table of the
selected pathways and DEGs presented within each pathway. e Array analysis Log2 fold change (FC) and false rate discovery (FDR) adjusted
p value of the selected genes for validation. f Diagram of the selection of candidate genes for validation.
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Fig. 2 Expression levels of validated genes in retroperitoneal adipose tissue of catch-up (R/C), non-catch-up (R/R), and control (C/C)
samples. Data are expressed as mean ± SEM, n= 16 rats per group. Linear ANOVA trend p value and unpaired T test, *p < 0.05, **p < 0.01,
and ***p < 0.001.
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Association of DEGs with body composition and metabolic
parameters
Correlation analysis showed significant associations between the
validated genes and several metabolic parameters, after correct-
ing for multiple comparisons (Table 2). Ccl21 showed negative
correlations with body weight at PD42, postnatal body weight
gain, plasma triglycerides, and HOMA-IR (all p < 0.05). Npr3
showed positive correlations with body weight at PD42, postnatal
body weight gain, amount of brown adipose tissue, plasma
triglycerides, and HOMA-IR (all p < 0.01). Serpina3n and Serpina12
showed positive correlations with body weight at PD42, postnatal
body weight gain, amount of white and brown adipose tissue,
plasma triglycerides, and HOMA-IR (all between p < 0.0001 and
≤0.001); and Serpina3n was negatively correlated with total plasma
adiponectin (Supplementary Fig. S2). Pnpla3 showed positive
correlations with body weight at PD42, postnatal body weight
gain, and the amount of white and brown adipose tissue and
HOMA-IR (all p ≤ 0.01). Slc2a4 showed positive correlations with
plasma triglycerides (all p < 0.05). Most of these associations were
maintained in multivariate regression analyses, adjusting for the
sex of the animals, with the exception of Slc2a4 that maintained
association only with triglycerides (data not shown).
DISCUSSION
Using the same rat model of catch-up growth that we previously
validated,21 we show for the first time a gene expression profile in
adipose tissue of juvenile rats with catch-up growth following
intrauterine restriction and report associations of several dysre-
gulated genes in adipose tissue with fat expansion and metabolic
parameters. We have compared restricted pups with and without
catch-up growth in order to study the exclusive effect of postnatal
growth on metabolic alterations. Given that low birth weight
children with catch-up growth can manifest early abnormalities at
school age15 and that adipose tissue has been identified as one of
the principal targets affected by catch-up growth,19,21 the data
obtained in this rat model provide interesting information
regarding the molecular mechanisms involved in the visceral fat
expansion and metabolic abnormalities following catch-up
growth.
The present results showed changes in the gene expression of
retroperitoneal adipose tissue in R/C group as compared to R/R.
Pathway enrichment analysis showed that DEGs were mainly
involved in six metabolic pathways, including immune and
inflammatory processes (regulation of leukocyte proliferation
and response to cytokines), lipid metabolic process, brown fat
cell differentiation, and upregulation of PI3K signalling. Dysregu-
lated gene expression of the studied genes occurred in parallel to
(a) fat expansion, as catch-up pups showed increased weight gain
from birth, increased weight at PD42, increased retroperitoneal
adipose tissue mass, and also hypertrophy of adipocytes in the
retroperitoneal adipose tissue;21 and (b) lipid and glucose
metabolism as catch-up pups showed increased levels of
triglycerides and HOMA-IR.21
Ccl21 expression has been described in adipocytes as well as in
dendritic cell/macrophage populations.27 Many articles report that
high fat diet-induced obesity enhances the expression of tissue
chemokines, including CCL21 and CCL19, during the course of
low-grade inflammation.28 Moreover, Ccl21 has been closely
related to atherosclerosis as its expression is elevated in ruptured
lesions of coronary arteries and in carotid plaques.29 Then,
dysregulated Ccl21 expression in retroperitoneal fat during
catch-up growth may contribute to atherosclerotic events29 or
impair immune system tissue responses.30
High Npr3 levels in adipose tissue of obese mice increased the
clearance of lipolytic atrial natriuretic peptide (ANP), abrogating its
locally lipolytic effect and thus contributing to obesity.31 The
regulation of Npr3 over lipolytic ANP may only be manifested in
states of low insulin action or in combination with other factors
(e.g., obesity) that contribute to pre-existing insulin resistance.31
As already shown by our research group, R/C rats exhibited an
insulin-resistant state;21 thus high Npr3 expressions in this context
Table 2. Correlations between Ccl21, Npr3, Serpina3n, Pnpla3, Slc2a4, and Serpina12 gene expression and body composition and metabolic parameters
in all R/C and R/R studied samples (N= 32).
Ccl21 Npr3 Serpina3n
r p r p r p
Body weight PD42 (g) −0.338 0.05 0.514 0.003 0.660 <0.0001
Postnatal body weight gain (g) −0.338 0.05 0.514 0.003 0.660 <0.0001
Retroperitoneal AT (g) −0.325 NS 0.353 0.04 0.598 <0.0001
Brown AT (g) −0.265 NS 0.477 0.007 0.695 <0.0001
Triglycerides (mmol/L) −0.484 0.01 0.580 0.005 0.660 0.001
HOMA-IR −0.415 0.05 0.529 0.01 0.647 0.001
Pnpla3 Slc2a4 Serpina12
r p r p r p
Body weight PD42 (g) 0.524 0.002 0.366 0.03 0.616 <0.0001
Postnatal body weight gain (g) 0.524 0.002 0.366 0.03 0.616 <0.0001
Retroperitoneal AT (g) 0.466 0.007 0.177 NS 0.595 <0.0001
Brown AT (g) 0.616 <0.0001 0.383 0.03 0.668 <0.0001
Triglycerides (mmol/L) 0.393 NS 0.573 0.005 0.654 0.001
HOMA-IR 0.530 0.01 0.179 NS 0.639 0.001
Values are expressed as ρ of Spearman’s bivariate correlation.
Significant associations after correcting for multiple comparisons (p ≤ 0.01) are shown in bold.
PD postnatal day, AT adipose tissue, HOMA-IR index homeostatic model assessment of insulin resistance, NS nonsignificant, p p value.
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may facilitate the observed altered metabolism and fat expansion.
Our results showed positive correlations of Npr3 with HOMA-IR
and also with body weight gain and the amount of brown adipose
tissue. The association with brown adipose tissue is in line with
observations from other authors describing that Npr3 can confer
thermogenic characteristics to rodent adipose tissues.32 Npr3
contribution to both obesity and enhancing thermogenesis may
seem contradictory at first sight, but a plausible explanation may
lie in the potential effect of Npr3 on beige adipocytes. Beige
adipocytes (basically white adipocytes that present brown
adipocyte characteristics) are observed during the browning of
white adipose tissues through the activation of natriuretic
peptides.32 Despite observing a similar expansion of both white
and brown adipose tissues in the catch-up growth group, the
browning of white adipose tissue may be different under catch-up
growth conditions. Thus, higher Npr3 during catch-up could at the
same time modulate white adipose tissue expansion and enhance
its thermogenic potential through a browning effect.
We also showed that Serpina3n was upregulated in retro-
peritoneal adipose tissue of R/C rats and was positively correlated
with postnatal body weight, weight gain, the amount of visceral
adipose tissue, and plasma triglycerides. Serpina3n, a serine
protease inhibitor that forms part of the SERPINA clade, is the
murine ortholog of the human anti-chymotrypsin and has been
identified as an inhibitor of both human and rodent granzyme B
in vitro.33 Recently, Serpina3n has been identified as a serum
biomarker in the development of the early stages of T2D and it is
believed that the increased expression of Serpina3n might
contribute to impaired insulin secretion in the pancreas in the
diabetic state.34,35 The same authors pointed out the possibility
that the increase in Serpina3n might reflect the obesity-related
phenotype, as the weight gain was more prominent in diabetic
than control rats. This is in line with the associations we observed
between Serpina3n and body composition during catch-up
growth in our juvenile rats. It is known that rats with intrauterine
restriction and postnatal catch-up growth show increased
susceptibility to diabetes mellitus in adulthood;36 therefore,
increased Serpina3n expression could facilitate the appearance
of T2D in these rats. Increase in Serpina3n expression was also
observed in response to inflammation in the hypothalamus of rats
subjected to high fat diet.37 Adiponectin, an anti-inflammatory
cytokine of the adipose tissue, is related to obesity-induced
chronic inflammation. In our study, total plasma adiponectin
was negatively correlated with Serpina3n, supporting that over-
expression of Serpina3n in R/C rats may be involved in
inflammatory responses under low-grade inflammation during
catch-up growth.
Pnpla3 encodes for a protein called adiponutrin or triacylgly-
cerol lipase involved in several lipid metabolic processes,
including lipid hydrolysis, and possibly also in energy balance
and storage in adipocytes.38 Pnpla3 has been described to drive
fatty acids excess into tissue lipid droplet storage,39 which
strengthens our data on its relation to increased visceral fat
depots and/or hypertrophy. Pnpla3 has also been related to liver
fat deposition.40 In fact, a well-known PNPLA3 polymorphism has
been identified as a childhood predictor of adulthood fatty
liver.41,42 The same variant of Pnpla3 has been associated with
metabolic and anthropometric T2D traits in adult patients with
metabolic syndrome.43 Moreover, increased Pnpla3 mRNA expres-
sion has been previously described in adult obese rats (both in
brown and white adipose tissue) and has been attributed to
vesicular targeting and protein transport between both types of
adipose tissue.44,45 These findings are consistent with our results
showing increased expression of Pnpla3 in catch-up rats and its
positive correlation with the amount of retroperitoneal (white) and
brown adipose tissue.
The expression of Slc2a4 was found to be significantly
increased in R/C as compared to R/R rats. Slc2a4 gene is a
member of the solute carrier family and encodes the GLUT4
protein. Slc2a4/Glut4, highly expressed in adipose tissue and
skeletal muscle, functions as an insulin-regulated facilitative
glucose transporter and is a key regulator of whole-body
glucose homeostasis.46 Several studies in animal models
showed decreased Slc2a4/Glut4 expression in offspring adipose
tissue after maternal undernutrition,23,47 although its expression
has also been described as being downregulated in adipose
tissue of obese subjects.48,49
We hypothesize that the Slc2a4 upregulation in adipose tissue
of R/C vs R/R rats may have a compensatory role to improve the
dysregulated insulin-resistant state observed in these catch-up
rats. An excess of glucose can be up-taken by adipocytes and
converted to glycerol as previously described in vitro in primary
cell cultures of adipocytes.50 The upregulation of Slc2a4 could thus
be a compensatory mechanism used by white adipose tissue to
convert the excess of glucose input into glycerol, not only to
dispose of the glucose excess but also to produce a more readily
usable metabolite and redistribute this secondary product into
other peripheral tissues.
In addition to being crucial for glucose uptake,51 augmented
PI3K signalling may cause exacerbated lipogenesis by increasing
the assortment of the required substrates from the citric acid
cycle. Serpina12 also known as vaspin (visceral adipose tissue-
derived serine protease inhibitor) has been associated with insulin
resistance, negative regulation of gluconeogenesis, and increased
carotid artery intima–media thickness in subjects with metabolic
syndrome.52 Moreover, this vaspin adipokine negatively regulates
lipid biosynthesis as it contributes to the metabolic regulation of
triglycerides in vitro51 and in vivo.53 Human studies have also
shown that mRNA expression of vaspin in the adipose tissue could
be induced by an increased fat mass.54 Our results head in the
same direction as previous investigations as Serpina12 positively
correlates with body weight and plasma triglycerides. In our
model, we observed increased Serpina12 expression in the
retroperitoneal adipose tissue in R/C rats, which was positively
correlated with both brown and white adipose tissue weight. We,
therefore, suggest that higher Serpina12 expression could
contribute to the visceral fat and brown adipose tissue expansion
in R/C rats.
To summarize, we have identified several dysregulated genes
(Ccl21, Npr3, Serpina3n, Pnpla3, Slc2a4, and Serpina12) in adipose
tissue of juvenile rats that could be involved in catch-up induced
visceral fat expansion and glucose and lipid metabolism.
However, we acknowledge some limitations in our study. The
study is mainly descriptive; nevertheless, the information
obtained from our array and validation increases knowledge
and may inspire other studies on adipose tissue during catch-up
growth. Moreover, other significant DEG genes could be chosen
for further studies such as angiopoietin-like proteins. The
selected Agt (angiotensinogen) did not get validated from our
array results; nonetheless, their implication in vascularization
and/or blood pressure regulation could be of study using
models assessed in later time-points until adulthood or aging.
On the other hand, retroperitoneal adipose tissue availability
was scarce in these animals, precluding the assessment of
protein expression as well as the separation of different cell
population fractions (e.g., adipocytes) from whole adipose tissue
samples, in order to complement the transcript gene expression
profile described in this study.
In conclusion, genes related to immune/inflammatory and
metabolic processes as well as brown fat cell differentiation were
upregulated in retroperitoneal adipose tissue following catch-up
growth in juvenile rats and were found to be associated with fat
expansion and metabolic parameters. Our results provide
evidence for several dysregulated genes in white adipose tissue
that could help develop novel strategies to prevent the metabolic
abnormalities associated with catch-up growth.
Catch-up growth in juvenile rats, fat expansion, and dysregulation of. . .
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